Deutsche Bank Ag\ Atara Biotherapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.44 - $1.22 $893 - $2,477	-2,031 Reduced 5.29%	36,353 $25,000
Q4 2023 Feb 14, 2024	SELL	$0.23 - $1.74 $80,500 - $609,000	-350,000 Reduced 90.12%	38,384 $19,000
Q3 2023 Nov 09, 2023	SELL	$1.41 - $2.31 $422,729 - $692,556	-299,808 Reduced 43.56%	388,384 $574,000
Q2 2023 Aug 14, 2023	SELL	$1.5 - $3.04 $30,075 - $60,952	-20,050 Reduced 2.83%	688,192 $1.11 Million
Q1 2023 May 15, 2023	BUY	$2.8 - $5.46 $49,733 - $96,980	17,762 Added 2.57%	708,242 $2.05 Million
Q4 2022 Feb 13, 2023	BUY	$2.85 - $5.18 $1,769 - $3,216	621 Added 0.09%	690,480 $2.26 Million
Q3 2022 Nov 14, 2022	BUY	$2.85 - $8.73 $1.83 Million - $5.62 Million	643,414 Added 1385.32%	689,859 $2.61 Million
Q2 2022 Aug 11, 2022	SELL	$4.69 - $9.84 $30,358 - $63,694	-6,473 Reduced 12.23%	46,445 $363,000
Q1 2022 May 13, 2022	SELL	$8.44 - $16.89 $108,985 - $218,100	-12,913 Reduced 19.62%	52,918 $492,000
Q4 2021 Feb 11, 2022	SELL	$14.7 - $19.89 $3.07 Million - $4.15 Million	-208,566 Reduced 76.01%	65,831 $1.04 Million
Q3 2021 Nov 04, 2021	SELL	$11.99 - $17.9 $16,522 - $24,666	-1,378 Reduced 0.5%	274,397 $4.91 Million
Q2 2021 Aug 11, 2021	SELL	$12.89 - $16.58 $17 Million - $21.9 Million	-1,321,452 Reduced 82.73%	275,775 $4.29 Million
Q1 2021 May 13, 2021	BUY	$14.0 - $20.72 $14.1 Million - $20.8 Million	1,003,847 Added 169.17%	1,597,227 $22.9 Million
Q4 2020 Feb 16, 2021	SELL	$12.67 - $26.23 $1.3 Million - $2.7 Million	-102,797 Reduced 14.77%	593,380 $11.6 Million
Q3 2020 Nov 12, 2020	SELL	$11.92 - $15.87 $1.03 Million - $1.37 Million	-86,607 Reduced 11.06%	696,177 $9.02 Million
Q2 2020 Aug 13, 2020	BUY	$7.53 - $14.93 $3.46 Million - $6.87 Million	460,113 Added 142.6%	782,784 $11.4 Million
Q1 2020 May 14, 2020	BUY	$5.69 - $17.78 $63,699 - $199,047	11,195 Added 3.59%	322,671 $2.75 Million
Q4 2019 Feb 14, 2020	BUY	$10.89 - $16.79 $2.64 Million - $4.08 Million	242,732 Added 353.1%	311,476 $5.13 Million
Q3 2019 Nov 14, 2019	SELL	$12.03 - $19.94 $2.68 Million - $4.44 Million	-222,495 Reduced 76.4%	68,744 $969,000
Q2 2019 Aug 14, 2019	BUY	$19.05 - $41.04 $3.1 Million - $6.68 Million	162,821 Added 126.79%	291,239 $5.85 Million
Q1 2019 May 15, 2019	SELL	$28.4 - $41.74 $2.63 Million - $3.87 Million	-92,666 Reduced 41.91%	128,418 $5.1 Million
Q4 2018 Feb 14, 2019	SELL	$30.9 - $42.97 $25,554 - $35,536	-827 Reduced 0.37%	221,084 $7.68 Million
Q3 2018 Dec 21, 2021	BUY	$35.05 - $43.5 $3.47 Million - $4.3 Million	98,869 Added 80.35%	221,911 $9.18 Million
Q3 2018 Nov 14, 2018	SELL	$35.05 - $43.5 $3.46 Million - $4.29 Million	-98,660 Reduced 44.5%	123,042 $5.09 Million
Q2 2018 Apr 21, 2020	BUY	$35.15 - $51.45 $814,003 - $1.19 Million	23,158 Added 11.66%	221,702 $8.15 Million
Q2 2018 Aug 14, 2018	SELL	$35.15 - $51.45 $2.13 Million - $3.12 Million	-60,725 Reduced 23.42%	198,544 $7.3 Million
Q1 2018 Oct 18, 2019	BUY	$18.0 - $48.35 $3.35 Million - $8.99 Million	186,011 Added 253.91%	259,269 $10.1 Million
Q1 2018 May 15, 2018	BUY	$18.0 - $48.35 $39,114 - $105,064	2,173 Added 3.06%	73,258 $2.86 Million
Q4 2017 Feb 14, 2018	BUY	$13.2 - $18.1 $601,458 - $824,726	45,565 Added 178.55%	71,085 $1.29 Million
Q3 2017 Nov 14, 2017	BUY	$13.25 - $17.05 $338,140 - $435,116	25,520	25,520 $421,000

Others Institutions Holding ATRA

# of Institutions

Shares Held

2.89M

Call Options Held

Put Options Held

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account